Home > Healthcare > Biotechnology > Biotechnology R&D > Biological Sample Collection Kits Market

Biological Sample Collection Kits Market Trends

Report ID: GMI6002
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Biological Sample Collection Kits Market Trends

The expansion of biobanking and personalized medicine has been a significant development in the field of healthcare and biomedical research. Biological sample collection kits play a crucial role in biobanking and personalized medicine by facilitating the collection, storage, and analysis of biological samples from individuals. These kits are designed to ensure the proper handling and preservation of various types of samples such as blood, saliva, urine, tissue, and DNA. In biobanking, sample collection kits are used to gather and store biological materials from individuals for research purposes. These samples are often linked to extensive clinical and phenotypic data, creating a valuable resource for studying various diseases, understanding genetic factors, and developing personalized treatments

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Biological sample collection kits industry was worth around USD 7.8 billion in 2022 and is projected to reach over USD 18.6 billion by 2032 attributed to the high demand for biological sample collection kits in diagnostic and research applications.

The swabs segment accounted for more than USD 2.7 billion in 2022 and is set to grow at a steady pace, driven by the onset of the COVID-19 pandemic and the subsequent implementation of widespread testing to identify and control the spread of the virus.

U.S. market for biological sample collection kits surpassed USD 2.3 billion in 2022 owing to the presence of key market players and rising awareness regarding early-stage disease diagnosis.

Some of the leading firms engaged in the biological sample collection kits business are Thermo Fisher Scientific, Inc., QIAGEN, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, and others.